Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
BJU Int
    January 2018
  1. BOSSCHIETER J, van Moorselaar RJA, Vis AN, van Ginkel T, et al
    The Effect of Timing of an Immediate Instillation with Mitomycin C after Transurethral Resection in 941 Non Muscle-invasive Bladder Cancer Patients.
    BJU Int. 2018 Jan 10. doi: 10.1111/bju.14124.
    >> Share

    December 2017
  2. MIYAKE M, Tatsumi Y, Matsumoto H, Nagao K, et al
    Outcomes of subsequent non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity matched analysis with primary bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14111.
    >> Share

  3. RITCH CR, Balise R, Soodana Prakash N, Alonzo D, et al
    Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle invasive bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109.
    >> Share


  4. Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer.
    BJU Int. 2017;120:755-765.
    >> Share

  5. MAURICE MJ, Kaouk JH
    Robotic radical perineal cystectomy and extended pelvic lymphadenectomy: initial investigation using a purpose-built single-port robotic system.
    BJU Int. 2017;120:881-884.
    >> Share

    November 2017
  6. AHMADI N, Clifford TG, Miranda G, Cai J, et al
    Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
    BJU Int. 2017;120:689-694.
    >> Share

  7. HUDDART RA, Birtle A, Maynard L, Beresford M, et al
    Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    BJU Int. 2017;120:639-650.
    >> Share

  8. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    >> Share

    October 2017
  9. XIA L, Taylor BL, Newton AD, Malhotra A, et al
    Early Discharge and Post-Discharge Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    BJU Int. 2017 Oct 24. doi: 10.1111/bju.14058.
    >> Share

  10. SMITH AB, Jaeger B, Pinheiro LC, Edwards LJ, et al
    The impact of bladder cancer on health-related quality of life.
    BJU Int. 2017 Oct 8. doi: 10.1111/bju.14047.
    >> Share

  11. LIEDBERG F, Gudjonsson S, Xu A, Bendahl PO, et al
    Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.
    BJU Int. 2017;120:530-536.
    >> Share

    September 2017
  12. PICHLER R, Fritz J, Tulchiner G, Klinglmair G, et al
    Increased Accuracy of a novel mRNA-based Urine Test for Bladder Cancer Surveillance.
    BJU Int. 2017 Sep 20. doi: 10.1111/bju.14019.
    >> Share

  13. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    >> Share

  14. LI R, Metcalfe MJ, Ferguson Rd JE, Mokkapati S, et al
    Effects of Thiazolidinedione in Patients with Active Bladder Cancer.
    BJU Int. 2017 Sep 5. doi: 10.1111/bju.14009.
    >> Share

  15. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    >> Share

  16. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    >> Share

  17. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    >> Share

  18. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    >> Share

    August 2017
  19. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    >> Share

  20. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    >> Share

    June 2017
  21. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    >> Share

  22. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    >> Share

  23. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    >> Share

    May 2017
  24. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    >> Share

  25. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    >> Share

  26. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    >> Share

  27. LAWRENTSCHUK N
    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    >> Share

  28. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    >> Share

    April 2017
  29. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    >> Share

  30. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    >> Share

  31. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    >> Share

    February 2017
  32. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    >> Share

    January 2017
  33. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    >> Share

  34. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    >> Share

    December 2016
  35. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    >> Share

    October 2016
  36. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    >> Share

  37. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    >> Share

  38. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    >> Share

  39. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    >> Share

  40. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    >> Share

    July 2016
  41. ONISHI T, Sugino Y, Shibahara T, Masui S, et al
    Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle invasive bladder cancer.
    BJU Int. 2016 Jul 22. doi: 10.1111/bju.13599.
    >> Share

  42. LOTAN Y
    Analysis of genetics to identify susceptibility to secondary malignancies in patients with bladder cancer.
    BJU Int. 2016;118:12-3.
    >> Share

  43. MOSTAFID AH
    Time to re-evaluate and refine re-transurethral resection in bladder cancer?
    BJU Int. 2016;118:9-10.
    >> Share

    June 2016
  44. CUMBERBATCH MG, Shellard BW, Catto JW
    The contemporary landscape of occupational bladder cancer within the United Kingdom: A meta-analysis of risks over the last 80 years.
    BJU Int. 2016 Jun 22. doi: 10.1111/bju.13561.
    >> Share

  45. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    >> Share

    May 2016
  46. HURLE R, Pasini L, Lazzeri M, Colombo P, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project.
    BJU Int. 2016 May 21. doi: 10.1111/bju.13536.
    >> Share

  47. KAMAT AM, Willis DL, Dickstein RJ, Anderson R, et al
    Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guerin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies.
    BJU Int. 2016;117:754-60.
    >> Share

    April 2016
  48. VARTOLOMEI MD, Kiss B, Vidal A, Burkhard F, et al
    Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
    BJU Int. 2016;117:618-28.
    >> Share

  49. CHEN EC, Papa N, Lawrentschuk N, Bolton D, et al
    Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience.
    BJU Int. 2016;117 Suppl 4:50-3.
    >> Share

    March 2016
  50. YADAV S, Tomar V, Yadav SS, Priyadarshi S, et al
    Role of oral PentosanPolysulphate in reduction of local side effects of BCG in Non muscle invasive Bladder Cancer patients: a pilot study.
    BJU Int. 2016 Mar 24. doi: 10.1111/bju.13489.
    >> Share

  51. ODDENS JR, Sylvester RJ, Brausi MA, Kirkels WJ, et al
    Increasing age is not associated with toxicity leading to discontinuation of treatment in urothelial non muscle invasive bladder cancer patients randomized to receive 3 years of maintenance bacillus Calmette-Guerin: Results from EORTC GU Group study 3
    BJU Int. 2016 Mar 6. doi: 10.1111/bju.13474.
    >> Share

  52. SATKUNASIVAM R, Hu B, Metcalfe C, Ghodoussipour SB, et al
    Utility and significance of ureteric frozen section analysis during radical cystectomy.
    BJU Int. 2016;117:463-8.
    >> Share

    February 2016
  53. SAMMON JD, Abdollah F, Klett DE, Pucheril D, et al
    The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy.
    BJU Int. 2016;117:211-2.
    >> Share

  54. AZIZ A, Shariat SF, Roghmann F, Brookman-May S, et al
    Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    BJU Int. 2016;117:272-9.
    >> Share

  55. ZEHNDER P, Moltzahn F, Mitra AP, Cai J, et al
    Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes.
    BJU Int. 2016;117:253-9.
    >> Share

    December 2015
  56. KOUPPARIS A, Villeda-Sandoval C, Weale N, El-Mahdy M, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol.
    BJU Int. 2015;116:924-31.
    >> Share

    November 2015
  57. ROLLE L, Falcone M, Ceruti C, Timpano M, et al
    A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the "Sliding Technique" for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
    BJU Int. 2015 Nov 11. doi: 10.1111/bju.13370.
    >> Share

  58. LOEB S, Ribal MJ
    Controversies in management of high-risk prostate and bladder cancer.
    BJU Int. 2015;116:675.
    >> Share

  59. SKINNER EC
    Is 42 days the 'magic number' for repeat transurethral resection of bladder tumour (TURBT)?
    BJU Int. 2015;116:678-9.
    >> Share

  60. TAN WS, Sridhar A, Goldstraw M, Zacharakis E, et al
    Robot-assisted intracorporeal pyramid neobladder.
    BJU Int. 2015;116:771-9.
    >> Share

  61. AL HUSSEIN AL AWAMLH B, Wang LC, Nguyen DP, Rieken M, et al
    Is continent cutaneous urinary diversion a suitable alternative to orthotopic bladder substitute and ileal conduit after cystectomy?
    BJU Int. 2015;116:805-14.
    >> Share

    October 2015
  62. GENDY R, Delprado W, Brenner P, Brooks A, et al
    Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    BJU Int. 2015 Oct 21. doi: 10.1111/bju.13265.
    >> Share

  63. WARREN H, Raison N, Dasgupta P
    Pioglitazone and Bladder Cancer.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13352.
    >> Share

  64. MULLER J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, et al
    Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351.
    >> Share

  65. RAMIREZ D, Gupta A, Canter D, Harrow B, et al
    Microscopic hematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    BJU Int. 2015 Oct 5. doi: 10.1111/bju.13345.
    >> Share

  66. IZQUIERDO L, Peri L, Leon P, Ramirez-Backhaus M, et al
    The role of cystectomy in elderly patients - a multicentre analysis.
    BJU Int. 2015;116 Suppl 3:73-9.
    >> Share

    September 2015
  67. VOSKOBOYNIK M, Rudman S, Arkenau HT, Hughes S, et al
    Immunotherapy for Bladder Cancer: Rediscovering an Old Friend.
    BJU Int. 2015 Sep 21. doi: 10.1111/bju.13330.
    >> Share

  68. PATEL MI, Bang A, Gillatt D, Smith DP, et al
    Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    BJU Int. 2015 Sep 2. doi: 10.1111/bju.13152.
    >> Share

    August 2015
  69. ROSE JB, Armstrong S, Hermann GG, Kjellberg J, et al
    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue- light cystoscopy in trans-urethral bladder tumour resection for non-muscle invasive bladder cancer patients in Sweden.
    BJU Int. 2015 Aug 25. doi: 10.1111/bju.13261.
    >> Share

  70. WILLIAMS SB, Kamat AM, Lamm DL
    Pelvic recurrence after radical cystectomy: a call to arms.
    BJU Int. 2015;116:172-3.
    >> Share

    July 2015
  71. O'REGAN T, Tatton M, Lyon M, Masters J, et al
    The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: A New Zealand Perspective.
    BJU Int. 2015 Jul 14. doi: 10.1111/bju.13211.
    >> Share

  72. GAKIS G, Stenzl A
    Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    BJU Int. 2015;116:3-4.
    >> Share

  73. WITJES JA
    Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
    BJU Int. 2015;116:2-3.
    >> Share

  74. VON RUNDSTEDT FC, Mata DA, Groshen S, Stein JP, et al
    Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
    BJU Int. 2015;116:44-9.
    >> Share

    June 2015
  75. ALBISINNI S, Rassweiler J, Abbou CC, Cathelineau X, et al
    Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.
    BJU Int. 2015;115:937-45.
    >> Share

    May 2015
  76. MCLATCHIE LM
    Could a dye offer a cheap and simple approach to detect bladder cancer using white-light cystoscopy?
    BJU Int. 2015 May 8. doi: 10.1111/bju.13177.
    >> Share

  77. LUCCA I, Roupret M, Kluth L, Rink M, et al
    Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    BJU Int. 2015;115:722-7.
    >> Share

  78. LEOW JJ, Reese S, Trinh QD, Bellmunt J, et al
    Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    BJU Int. 2015;115:713-21.
    >> Share

  79. ISHIOKA J, Saito K, Kijima T, Nakanishi Y, et al
    Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    BJU Int. 2015;115:705-12.
    >> Share

    April 2015
  80. TOLCHARD S, Angell J, Pyke M, Lewis S, et al
    Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
    BJU Int. 2015;115:554-61.
    >> Share

  81. PHE V, Roupret M, Cussenot O, Chartier-Kastler E, et al
    Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    BJU Int. 2015;115 Suppl 6:28-32.
    >> Share

    December 2014
  82. BAACK KUKREJA JE, Scosyrev E, Brasacchio RA, Toy EP, et al
    Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
    BJU Int. 2014;114:844-51.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016